Bladder: Risk and prognostic factors - A pathologist's perspective Article Report uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Drug Resistance, Neoplasm
  • Gene Expression Profiling
  • Neoplasms, Germ Cell and Embryonal

abstract

  • Morphology remains a power tool to help predict the risk of recurrence, progression, and even response to therapy in bladder cancer. Nevertheless, more work is needed to refine and standardize criteria and terminology. Novel molecular tools may reveal prognostic factors, but these techniques must be compared with standard morphologic and clinical markers by performing multivariate analysis in a prospective fashion.

publication date

  • September 8, 1999

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0094-0143(05)70196-8

PubMed ID

  • 10494286

Additional Document Info

start page

  • 481

end page

  • 92

volume

  • 26

number

  • 3